AmerisourceBergen Corporation, ABC is in the exchange NYSE and its industry is Drugs Wholesale in the sector of Services. Based in USA, AmerisourceBergen Corporation, ABC has a market cap of 19804.34. Since its IPO date on the 4/4/1995, AmerisourceBergen Corporation, ABC performance year to date is -18.74%. Today AmerisourceBergen Corporation, ABC has gained 0.64%, with a current price of 83.25.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 69.10%. The management of the company have seen the company have a payout ratio of 16.70%. Return of assets are at 5.40%, with return on investment at -0.50%.
In terms of debt levels and profit levels, AmerisourceBergen Corporation, ABC is seeing a long-term debt/equity of 2.02. While Total debt/equity is 2.35. With a profit margin of 1.10%, this is combined with a gross margin of 2.90%, and operating margin of 1.20%. AmerisourceBergen Corporation ability to meet debt levels, with a current ratio of 0.9, while the quick ratio is 0.5.
For the last year AmerisourceBergen Corporation, ABC has seen a EPS growth of -151.30%. A performance for the year of -12.08%. The 52-week high is -20.35%, and the 52-week low is 14.15%. The average volume for AmerisourceBergen Corporation, ABC is 1582200.
With a target price of 92.54, can AmerisourceBergen Corporation, ABC reach this target? Looking at the value indicators of AmerisourceBergen Corporation, ABC. AmerisourceBergen Corporation has a P/E of 11.23 and a forward P/E of 14.24. Perhaps the more useful indicator than P/E, is PEG which has a value of 1.06. AmerisourceBergen Corporation also has a P/S and a P/B of 0.14 and 9.56 respectively. For P/cash, AmerisourceBergen Corporation has a value of 10.62, while it is 8.53 for P/free cash flow.
At the current price of 83.25, AmerisourceBergen Corporation has a dividend yield of 1.63%. We see a return on equity of 109.80%.
Looking more long-term AmerisourceBergen Corporation, is projected to get an EPS growth for the next five years of 10.63%. In the short-term an EPS growth of 5.30% in the next year is forecasted. This is after a EPS growth of -151.30% for this year and for the last five years a -17.90% growth has been seen.